216 related articles for article (PubMed ID: 21518552)
21. Analyses of pancreas transplant outcomes for United States cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 1999; ():51-69. PubMed ID: 11038625
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
[TBL] [Abstract][Full Text] [Related]
23. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.
Castro MC; Araujo LM; Nahas WC; Arap S; David-Neto E; Ianhez LE
Transplant Proc; 2004 May; 36(4):874-6. PubMed ID: 15194299
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive regimens and their effects on renal allograft outcome.
Katznelson S; Cecka JM
Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
26. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
27. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
Cecka JM; Terasaki PI
Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
[TBL] [Abstract][Full Text] [Related]
28. The UNOS Scientific Renal Transplant Registry--1990.
Cecka JM; Terasaki PI
Clin Transpl; 1990; ():1-10. PubMed ID: 2103135
[TBL] [Abstract][Full Text] [Related]
29. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
30. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
[TBL] [Abstract][Full Text] [Related]
31. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
32. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
33. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
34. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
35. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
36. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients.
Zaltzman JS; Boucher A; Busque S; Halloran PF; Landsberg DN; McAlister VC; Russell D; Shoker A; Shapiro J; Tchervenkov JI; Ferguson R
Clin Transplant; 2005 Feb; 19(1):26-32. PubMed ID: 15659130
[TBL] [Abstract][Full Text] [Related]
37. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
38. UNOS Registry data: effect of transfusions.
Cicciarelli J
Clin Transpl; 1990; ():407-16. PubMed ID: 2103162
[TBL] [Abstract][Full Text] [Related]
39. Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.
Kute VB; Vanikar AV; Trivedi HL; Shah PR; Goplani KR; Patel HV; Gumber MR; Patel RD; Kanodia KV; Suthar KS; Trivedi VB; Modi PR
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):662-9. PubMed ID: 21743208
[TBL] [Abstract][Full Text] [Related]
40. Sensitization.
Ogura K
Clin Transpl; 1992; ():357-69. PubMed ID: 1306712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
